New trials for cancer patients at Sarah Cannon Research Institute - European Medical Journal

New trials for cancer patients at Sarah Cannon Research Institute

Oncology

At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Hendrik-Tobias Arkenau, MD, PhD, of Sarah Cannon Research Institute, UK, explains that the development of immunotherapies for a variety of cancer types and specific cancer proteins is a very active area of research at Sarah Cannon Research Institute.

Join our mailing list

To receive the EMJ updates straight to your inbox free of charge, please click the button below.
Join Now